Research News and Research

RSS

Research shows sex change hormonal treatment also changes brain chemistry

Hormonal treatments administered as part of the procedures for sex reassignment have well-known and well-documented effects on the secondary sexual characteristics of the adult body, shifting a recipient's physical appearance to that of the opposite sex.

9 Oct 2015

Pitt research team awarded NIH grant to study impact of substance abuse on adolescent brain development

A research team in the department of psychiatry, at the University of Pittsburgh, has been awarded a $5 Million National Institutes of Health grant to participate in a multi-site study focusing on the impact of adolescent marijuana, alcohol and other drug use on the developing brain.

9 Oct 2015

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.

9 Oct 2015

Researchers reveal new subtypes of invasive lobular carcinoma

Researchers from the UNC Lineberger Comprehensive Cancer Center and other academic centers have revealed new subtypes of invasive lobular carcinoma, the second most commonly diagnosed invasive breast cancer type. The findings could lead to personalized treatment approaches for the disease.

9 Oct 2015

Aristada (aripiprazole lauroxil) extended release injection approved to treat adults with schizophrenia

On October 5, the U.S. Food and Drug Administration approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a health care professional every four to six weeks using an injection in the arm or buttocks.

9 Oct 2015

Research finding could lead to new treatments for celiac disease

A team of researchers has discovered that bacteria found in the gut may contribute to the body's response to gluten, an important finding that could lead to new treatments for celiac disease.

9 Oct 2015

ASA: Epidural or spinal anesthesia preferred for most cesarean deliveries

New research could ease the minds of expectant mothers who may be nervous about epidurals or spinal anesthesia for childbirth. A study of New York state hospitals, published in the Online First edition of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, found the rate of anesthesia-related complications in women who received epidural or spinal anesthesia for cesarean delivery decreased 25 percent over the past decade.

9 Oct 2015

One World Lab announces collaboration with BenchWise to improve antibody research

Antibodies are among the most commonly used reagents in life-science laboratories employed in everyday experiments, diagnostics and clinical tests. The specificity displayed by antibodies makes them versatile lab tools; however, sourcing the most appropriate antibody can be costly and time consuming

9 Oct 2015

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

The U.S. Food and Drug Administration today approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve blood sugar (glucose) control in adults with diabetes mellitus.

9 Oct 2015

Roy D. Patterson selected to receive ASA's Silver Medal in Psychological and Physiological Acoustics

Roy D. Patterson, Emeritus Professor at the University of Cambridge, Cambridge, UK, has been named recipient of the Acoustical Society of America's Silver Medal in Psychological and Physiological Acoustics for contributions to understanding pitch and timbre perception, and for computational modeling of auditory representations.

9 Oct 2015

Varubi (rolapitant) approved to prevent delayed phase chemotherapy-induced nausea and vomiting

The U.S. Food and Drug Administration approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting (emesis). Varubi is approved in adults in combination with other drugs (antiemetic agents) that prevent nausea and vomiting associated with initial and repeat courses of vomit-inducing (emetogenic and highly emetogenic) cancer chemotherapy.

9 Oct 2015

ED physicians make key changes in clinical decision-making after viewing CT scan results

A study from the Massachusetts General Hospital Institute for Technology assessment finds that, after viewing CT scan results, physicians in the emergency departments of four major academic medical centers made key changes in clinical decision-making for patients with symptoms frequently seen in emergency rooms.

9 Oct 2015

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

The U.S. Food and Drug Administration today approved Vraylar (cariprazine) capsules to treat schizophrenia and bipolar disorder in adults.

9 Oct 2015

Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

The Brain & Behavior Research Foundation will honor nine scientists with its 2015 Outstanding Achievement Prizes for their work in schizophrenia, mood disorders, child and adolescent psychiatry, and cognitive neuroscience.

9 Oct 2015

Scientists create first 3-D image of key protein involved in development of cancers

Scientists from New Zealand and Australia have created the first three-dimensional image of a key protein involved in the development of blood and other cancers.

9 Oct 2015

Repatha (evolocumab) injection gets FDA approval for high cholesterol

The U.S. Food and Drug Administration today approved Repatha (evolocumab) injection for some patients who are unable to get their low-density lipoprotein (LDL) cholesterol under control with current treatment options.

9 Oct 2015

Manchester researchers demonstrate safety, effectiveness of eltrombopag treatment in children with ITP

Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.

9 Oct 2015

New study examines factors that may protect transgender individuals from attempting suicide

The likelihood of a transgender person attempting suicide is very high, often because of the prejudice, transphobia and other stressors he or she may experience. A new study examined factors that may protect transgender adults from attempting suicide. Its conclusions also inform medical and mental health professionals who work with transgender clients.

9 Oct 2015

NIH launches new Breast Cancer and the Environment Research Program focused on prevention

A new phase of the Breast Cancer and the Environment Research Program (BCERP), focused on prevention, is being launched at the National Institutes of Health. Grant-funded researchers will now work across scientific disciplines, involve new racially and ethnically diverse communities, and expand the study of risk factors that precede breast cancer, such as breast density.

9 Oct 2015

People with restless legs syndrome at higher risk for stroke, heart and kidney disease

Imagine trying to lie down and rest but feeling an uncontrollable urge to keep moving your legs. That, in a nutshell, is the ongoing ordeal facing people with restless legs syndrome. Considered a neurological, sleep, or movement disorder, RLS affects up to 1 in 10 people in the U.S. For those coping with a more severe form of RLS, countless sleepless nights--during which they may toss and turn constantly, or get up and pace the floor--can shatter quality of life.

9 Oct 2015

Research News and Research

Research shows sex change hormonal treatment also changes brain chemistry

Pitt research team awarded NIH grant to study impact of substance abuse on adolescent brain development

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

Researchers reveal new subtypes of invasive lobular carcinoma

Aristada (aripiprazole lauroxil) extended release injection approved to treat adults with schizophrenia

Research finding could lead to new treatments for celiac disease

ASA: Epidural or spinal anesthesia preferred for most cesarean deliveries

One World Lab announces collaboration with BenchWise to improve antibody research

Tresiba and Ryzodeg approved to improve blood sugar control in adults with diabetes mellitus

Roy D. Patterson selected to receive ASA's Silver Medal in Psychological and Physiological Acoustics

Varubi (rolapitant) approved to prevent delayed phase chemotherapy-induced nausea and vomiting

ED physicians make key changes in clinical decision-making after viewing CT scan results

Vraylar (cariprazine) capsules now approved by FDA to treat schizophrenia, bipolar disorder in adults

Brain & Behavior Research Foundation to honor nine scientists with Outstanding Achievement Prizes

Scientists create first 3-D image of key protein involved in development of cancers

Repatha (evolocumab) injection gets FDA approval for high cholesterol

Manchester researchers demonstrate safety, effectiveness of eltrombopag treatment in children with ITP

New study examines factors that may protect transgender individuals from attempting suicide

NIH launches new Breast Cancer and the Environment Research Program focused on prevention

People with restless legs syndrome at higher risk for stroke, heart and kidney disease

Industry Focus eBook - Life Science Microscopy (3rd Edition) eBook

Latest eBooks

Editorial Focus eBook - Proteomics (2nd Edition)

Industry Focus eBook - Life Science Microscopy (3rd Edition)

BFEB: Advances in microplate-based assays and analysis

Biologics stability screening toolkit: Three practical workflows for accelerating formulation development

Lab Matters host Harriet Gould on building a more connected lab community

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation